| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Scott Letendre | Q75155595 |
| Sara Gianella | Q90282543 | ||
| P2860 | cites work | Human T cell aging and the impact of persistent viral infections | Q21131206 |
| Cytomegalovirus infection causes an increase of arterial blood pressure | Q21131578 | ||
| Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection | Q28079533 | ||
| The Sordid Affair Between Human Herpesvirus and HIV | Q28083192 | ||
| Decoding human cytomegalovirus | Q28279933 | ||
| The end of AIDS: HIV infection as a chronic disease | Q28300749 | ||
| Herpesvirus latency confers symbiotic protection from bacterial infection | Q28302729 | ||
| Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm | Q28304034 | ||
| Cytomegalovirus infection enhances the immune response to influenza. | Q30300254 | ||
| Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease | Q33528999 | ||
| Immune activation and HIV persistence: considerations for novel therapeutic interventions | Q33698781 | ||
| Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection | Q33779043 | ||
| Is HIV a model of accelerated or accentuated aging? | Q33792651 | ||
| Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States | Q33838430 | ||
| Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. | Q51016644 | ||
| Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. | Q51568906 | ||
| The influence of latent viral infection on rate of cognitive decline over 4 years. | Q51914404 | ||
| CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. | Q52018126 | ||
| Comment on "cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals," journal of infectious diseases, 8 august 2014. | Q53361241 | ||
| Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. | Q54587707 | ||
| Successful Aging | Q55895195 | ||
| Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy | Q58473814 | ||
| HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus | Q60343453 | ||
| Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis | Q69349578 | ||
| A prospective study of primary cytomegalovirus infection during pregnancy: final report | Q70200523 | ||
| Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells | Q71206195 | ||
| Human cytomegalovirus alters interleukin-6 production by endothelial cells | Q72720714 | ||
| Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC | Q73677700 | ||
| Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women | Q81722105 | ||
| Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis | Q82102394 | ||
| Latency and reactivation of human cytomegalovirus | Q83946800 | ||
| Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread? | Q84993325 | ||
| Cytomegalovirus and immunological aging: the real driver of HIV and heart disease? | Q44937735 | ||
| Cytomegalovirus: an improbable cause of Alzheimer disease. | Q44941081 | ||
| An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness | Q45723851 | ||
| Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease | Q45767261 | ||
| Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type | Q45877119 | ||
| Cytomegalovirus infection inhibits the expression of N-methyl-D-aspartate receptors in the developing mouse hippocampus and primary neuronal cultures | Q46368680 | ||
| Persistent cytomegalovirus infection of semen increases risk of AIDS. | Q46605611 | ||
| Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. | Q50649143 | ||
| Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study | Q33880835 | ||
| Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. | Q33900251 | ||
| Heterologous immunity between viruses | Q34051846 | ||
| Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. | Q34125560 | ||
| A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis | Q34137496 | ||
| Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up | Q34179430 | ||
| Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses | Q34308375 | ||
| Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease | Q34342133 | ||
| Immune senescence: relative contributions of age and cytomegalovirus infection | Q34390507 | ||
| Strategies for successful aging: a research update | Q34393222 | ||
| Correlates of self-rated successful aging among community-dwelling older adults. | Q34483800 | ||
| RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima | Q34712927 | ||
| Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells | Q35024214 | ||
| Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals | Q35043697 | ||
| Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals | Q35078551 | ||
| CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals | Q35095403 | ||
| Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging | Q35107330 | ||
| Successful aging and the epidemiology of HIV. | Q35137873 | ||
| Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging | Q35312255 | ||
| Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity | Q35849804 | ||
| Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study | Q35960698 | ||
| High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage | Q35990663 | ||
| Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda | Q35993475 | ||
| Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus | Q36146446 | ||
| Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women | Q36154044 | ||
| Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. | Q36167258 | ||
| Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age | Q36296547 | ||
| Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction | Q36384581 | ||
| Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects | Q36402863 | ||
| CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection | Q36446109 | ||
| Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal | Q36587164 | ||
| Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. | Q36607261 | ||
| Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers | Q36622848 | ||
| Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality | Q36684512 | ||
| Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection. | Q36736353 | ||
| Cytomegalovirus is associated with reduced telomerase activity in the Whitehall II cohort | Q36765175 | ||
| HIV infection and immune activation: the role of coinfections | Q36796783 | ||
| Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. | Q36905563 | ||
| A case-controlled study of successful aging in older HIV-infected adults | Q36932766 | ||
| Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia | Q37026506 | ||
| Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease | Q37037056 | ||
| Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) | Q37113833 | ||
| Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. | Q37393465 | ||
| Insights into the role of infection in atherogenesis and in plaque rupture | Q37527507 | ||
| War and peace between microbes: HIV-1 interactions with coinfecting viruses | Q37633738 | ||
| Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications | Q37677640 | ||
| Role of CMV in immune senescence | Q37792338 | ||
| Possible role of cytomegalovirus in atherogenesis | Q37875443 | ||
| Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease | Q37875480 | ||
| Human cytomegalovirus infection and atherothrombosis | Q37967568 | ||
| HIV and inflammation: mechanisms and consequences | Q38005046 | ||
| HIV infection and atherosclerosis: evaluating the drivers of inflammation | Q38007417 | ||
| Immune response to CMV in solid organ transplant recipients: current concepts and future directions | Q38011227 | ||
| Immunosenescence and HIV. | Q38015598 | ||
| Cytomegalovirus, aging, and HIV: a perfect storm | Q38029533 | ||
| Treatment of cytomegalovirus infections beyond acute disease to improve human health | Q38176940 | ||
| Residual inflammation and viral reservoirs: alliance against an HIV cure | Q38269458 | ||
| The silent war of CMV in aging and HIV infection | Q38592494 | ||
| The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence | Q38698736 | ||
| T cell responses to cytomegalovirus | Q38815977 | ||
| Immune resilience in HIV-infected individuals seronegative for cytomegalovirus. | Q39269283 | ||
| Letermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent | Q39325580 | ||
| Induction of CMV-1 promoter by 4-hydroxy-2-nonenal in human embryonic kidney cells | Q39698579 | ||
| Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus | Q40347358 | ||
| Short Communication: Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy? | Q40791597 | ||
| The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus | Q41212001 | ||
| HCMV induces dysregulation of glutamate uptake and transporter expression in human fetal astrocytes | Q41712134 | ||
| In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits | Q41810722 | ||
| Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients | Q42202541 | ||
| Presence of cytomegalovirus DNA in leucocytes is associated with increased oxidative stress and subclinical atherosclerosis in healthy adults | Q42232103 | ||
| Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy | Q42720721 | ||
| Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status | Q43415731 | ||
| Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses | Q43717389 | ||
| No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study | Q43971598 | ||
| Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection | Q44557383 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P304 | page(s) | S67-74 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Cytomegalovirus and HIV: A Dangerous Pas de Deux | |
| P478 | volume | 214 Suppl 2 |
| Q59355087 | Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers |
| Q64967215 | CMV Primes Functional Alternative Signaling in Adaptive Δg NK Cells but Is Subverted by Lentivirus Infection in Rhesus Macaques. |
| Q90683081 | CMV seropositivity is associated with increased microbial translocation in people living with HIV and uninfected controls |
| Q63740305 | Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses |
| Q61807009 | Cytokine-Mediated Induction and Regulation of Tissue Damage During Cytomegalovirus Infection |
| Q30377601 | Cytomegalovirus Acquisition and Inflammation in Human Immunodeficiency Virus-Exposed Uninfected Zimbabwean Infants. |
| Q91673193 | Cytomegalovirus ventriculoencephalitis presenting with hydrocephalus in a patient with advanced HIV infection |
| Q90026325 | Cytomegalovirus viremia associated with increased mortality in cryptococcal meningitis in sub-Saharan Africa |
| Q92589802 | Cytomegalovirus-specific CD8+ T-cell responses are associated with arterial blood pressure in people living with HIV |
| Q92315395 | DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection? |
| Q40129331 | Effect of CMV and EBV replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals |
| Q38851448 | Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation |
| Q47267247 | Epstein-Barr Virus, but Not Cytomegalovirus, Latency Accelerates the Decay of Childhood Measles and Rubella Vaccine Responses-A 10-Year Follow-up of a Swedish Birth Cohort |
| Q93053174 | Extracellular vesicles and chronic inflammation during HIV infection |
| Q63677376 | HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study |
| Q51748805 | Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals. |
| Q54262086 | Higher Anti-CMV IgG Concentrations are Associated with Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. |
| Q50200827 | Human Immunodeficiency Virus in the Brain-Culprit or Facilitator? |
| Q89515974 | Human inborn errors of immunity to herpes viruses |
| Q89977601 | Inhibition of Human Cytomegalovirus Entry into Host Cells Through a Pleiotropic Small Molecule |
| Q36238363 | Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients |
| Q33585386 | Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. |
| Q63677379 | Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa |
| Q91738965 | Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a |
| Q41718407 | Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery |
| Q59807865 | Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi |
| Q98467142 | Sex Differences in CMV Replication and HIV Persistence During Suppressive ART |
| Q44174979 | T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection. |
| Q99345912 | The host exosome pathway underpins biogenesis of the human cytomegalovirus virion |
| Q47133365 | The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia. |
| Q95649085 | Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells |
| Q97640542 | Venous thromboembolism in people living with HIV infection (PWH) |
Search more.